1. Home
  2. OGN vs NNNN Comparison

OGN vs NNNN Comparison

Compare OGN & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$5.85

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$23.92

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
NNNN
Founded
1923
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
OGN
NNNN
Price
$5.85
$23.92
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$11.75
N/A
AVG Volume (30 Days)
3.0M
26.3K
Earning Date
04-30-2026
04-28-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
$6,216,000,000.00
N/A
Revenue This Year
$0.42
N/A
Revenue Next Year
$1.67
N/A
P/E Ratio
$8.42
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$5.76
$5.91
52 Week High
$14.94
$55.65

Technical Indicators

Market Signals
Indicator
OGN
NNNN
Relative Strength Index (RSI) 25.56 52.80
Support Level N/A $19.53
Resistance Level $7.87 $30.70
Average True Range (ATR) 0.22 1.97
MACD 0.00 0.41
Stochastic Oscillator 10.00 84.48

Price Performance

Historical Comparison
OGN
NNNN

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: